Pliant Therapeutics, Inc.

NASDAQ:PLRX

Biotechnology

Healthcare
$0.81 -3.39%

-$0.04 today

Market cap
$50.14M
Beta
1.21
P/E (TTM)
-0.6
EPS (TTM)
-$1.83
52W Low $1.09High $1.95

Volume 0.15M

Average 0.49M

Balance Sheet

Inspect the capital base behind the business.

Assets

$225.23M

FY 2025 · Annual

-43.3% YoY

Liabilities

$44.02M

FY 2025 · Annual

-52.6% YoY

Equity

$181.21M

FY 2025 · Annual

-40.4% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents51.67M33.69M63.23M71.19M45.45M
Short-term Investments148.93M297.5M431.01M284.54M145.5M
Net Receivables2.47M3.14M3M2.3M823K
Inventory00000
Other Current Assets156K173K1.27M163K1.13M
Total Current Assets209.44M340.31M505.5M362.26M196.45M
Property, Plant & Equipment (Net)10.94M9.91M4.78M32.77M25.01M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets838K394K1.87M1.92M3.77M
Total Non-current Assets11.77M10.3M6.65M34.69M28.78M
Total Assets221.22M350.61M512.15M396.95M225.23M
Account Payables2.97M1.58M4.53M5.96M480K
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities5.22M7.2M9.04M11.15M8.3M
Total Current Liabilities16.83M23.91M28.52M33.22M16.37M
Long-term Debt09.93M10.05M30.21M0
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities5.33M13.36M10.05M59.65M27.66M
Total Liabilities22.16M37.27M38.58M92.87M44.02M
Common Stock3K5K6K6K6K
Retained Earnings(215.09M)(338.41M)(499.75M)(710.05M)(859.4M)
Accumulated OCI(201K)(1.96M)345K321K(15K)
Other Stockholders Equity00000
Minority Interest00000
Total Equity199.06M313.34M473.58M304.08M181.21M
Total Debt7.19M15.82M11.37M60.19M29.11M
Net Debt(44.47M)(17.87M)(51.86M)(11M)(16.34M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$22.2M
Short-term Investments$148.7M
Receivables$914.0K
Other Current$3.1M
Total Current Assets$174.9M
PP&E (Net)$24.0M
Other Non-current$3.6M
Total Non-current Assets$27.7M
Total Assets$202.6M

Analysis

Selected assets total $202.6M for Latest. The largest visible component is Short-term Investments at $148.7M, about 73.4% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipOct 2, 2026
3Initial statement of beneficial ownershipOct 2, 2026
SC 13GSC 13G filingAug 14, 2026
SC 13G/ASC 13G/A filingAug 14, 2026
8-KCurrent reportAug 11, 2026

How much cash does PLRX have?

Pliant Therapeutics, Inc. (PLRX) reported $45.45M in cash and equivalents in fiscal 2025.

How much debt does PLRX carry?

Pliant Therapeutics, Inc. (PLRX) reported $29.11M of total debt, with net debt of -$16.34M.